eXtenZone capsules recalled for containing unapproved drug ingredients
SS Wholesale Inc. is recalling eXtenZone capsules because FDA analysis found undeclared desmethyl carbondenafil and dapoxetine, making the product an unapproved new drug.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
SS Wholesale Inc. dba Jobbers Wholesale is recalling eXtenZone capsules, 1 capsule per blister pack, distributed by P.M.C. Company in Buena Park, CA. The product is marketed as a dietary supplement but was found to contain undeclared desmethyl carbondenafil and dapoxetine.
FDA analysis determined that desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitor, a class of drugs used to treat male erectile dysfunction. The presence of this ingredient makes the product an unapproved new drug. Dapoxetine is also an active ingredient not approved by the FDA for this use.
The recall involves 2,395 blister packs total for all products, with a distribution pattern limited to California. The specific lot number is KWAKPMC03050517 with an expiration date of 12/16. Consumers should stop using the product and contact the distributor or manufacturer for further instructions.
The recalled product
- Product
- eXtenZone capsules, 1 capsule per blister pack, Distributed by: P.M.C. Company, Buena Park, CA 90621, UPC 6 89076 49126 6.
- Manufacturer
- SS Wholesale Inc. dba Jobbers Wholesale
- Category
- Drug — Dietary Supplement
- Affected units
- 2,395
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: KWAKPMC03050517
- Exp 12/16
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 3 recalled by SS Wholesale Inc. dba Jobbers Wholesale under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · SS Wholesale Inc. dba Jobbers Wholesale
See all →- CriticalFDA Recalls Rhino 5 Capsules Containing Unapproved Drug Ingredients
FDA (Drugs) · 2014-02-05
- CriticalMaXtremeZEN Capsules Recalled for Containing Unapproved Drug Ingredients
FDA (Drugs) · 2014-02-05
Same hazard · undeclared drug ingredient
See all →- SevereBlue Bull male enhancement supplement pouches contain undeclared sildenafil
FDA (Food) · 2026-04-15
- SevereRed Bull male enhancement supplement pouches contain undeclared sildenafil
FDA (Food) · 2026-04-15
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04
- CriticalMale supplement capsules recalled after FDA analysis found tadalafil
FDA (Drugs) · 2026-02-11
- SevereDietary Supplement ULTRA ARMOR Recalled for Undeclared Drug Ingredients
FDA (Drugs) · 2025-06-18
Similar recalls
- CriticalFDA Recalls 7K Capsules Containing Undeclared Sildenafil and Tadalafil
FDA (Drugs) · 2018-06-06
- SevereNUX Male Enhancement Capsules Recalled for Undeclared Prescription Ingredients
FDA (Drugs) · 2023-05-10
- SevereUnapproved Drug Capsule Recalled for Undeclared Sexual Enhancement Ingredients
FDA (Drugs) · 2023-05-10
- SeverePrimeZEN Black 6000 Capsule Recalled for Undeclared Pharmaceutical Ingredients
FDA (Drugs) · 2023-03-08
- SevereXZone 1200 Recalled for Undeclared Erectile Dysfunction Ingredients
FDA (Drugs) · 2014-09-24
- SevereP-Boost Capsules Recalled for Undeclared Tadalafil Ingredient
FDA (Drugs) · 2014-05-28